A Study to Assess the Safety of Myozyme® and of Aldurazyme® in Male and Female Participants of Any Age Group With Pompe Disease or With Mucopolysaccharidosis Type I (MPS I) in a Home-care Setting

NCT05073783 · clinicaltrials.gov ↗
COMPLETED
Status
57
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Sanofi